<DOC>
	<DOC>NCT00272558</DOC>
	<brief_summary>The purpose is to evaluate the activity and feasibility of a two drug regimen which is partly orally and partly intravenous in advanced pleural mesothelioma.</brief_summary>
	<brief_title>Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma</brief_title>
	<detailed_description>Chemotherapy with carboplatin i.v. day one in each cycle Vinorelbine i.v. day one, and orally day 8 in each cycle, repeat new cycle every 3 weeks. Total of 6 cycles. Endpoint is response rate, secondary endpoints survival and toxicity.</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Histologically verified malignant pleural Mesothelioma Age above 18 years Performance status 02 No previous chemotherapy Normal renal, liver and bone marrow function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Malignant Pleural Mesothelioma</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>